Carisma Therapeutics Inc (NASDAQ: CARM) is -75.87% lower on its value in year-to-date trading and has touched a low of $0.14 and a high of $1.42 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CARM stock was last observed hovering at around $0.42 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $0.4, the stock is -8.98% and 36.12% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.4 million and changing -4.05% at the moment leaves the stock -25.38% off its SMA200. CARM registered -3.77% loss for a year compared to 6-month loss of -8.64%. The firm has a 50-day simple moving average (SMA 50) of $0.29612 and a 200-day simple moving average (SMA200) of $0.54011.
The stock witnessed a 126.79% gain in the last 1 month and extending the period to 3 months gives it a 81.37%, and is -0.84% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.59% over the week and 22.15% over the month.
Carisma Therapeutics Inc (CARM) has around 46 employees, a market worth around $16.84M and $19.96M in sales. Profit margin for the company is -254.28%. Distance from 52-week low is 184.40% and -71.62% from its 52-week high.
The EPS is expected to grow by 50.00% this year
44.0 institutions hold shares in Carisma Therapeutics Inc (CARM), with institutional investors hold 43.96% of the company’s shares. The shares outstanding are 41.79M, and float is at 21.12M with Short Float at 14.70%. Institutions hold 31.76% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 1.45 million shares valued at $2.2 million. The investor’s holdings represent 3.4861 of the CARM Shares outstanding. As of 2024-06-30, the second largest holder is TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA with 1.25 million shares valued at $1.9 million to account for 3.014 of the shares outstanding. The other top investors are TPG GP A, LLC which holds 0.84 million shares representing 2.0269 and valued at over $1.28 million, while BLACKROCK INC. holds 1.7091 of the shares totaling 0.71 million with a market value of $1.08 million.
